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Comparison of three therapeutic regimens in eradication of Helicobacter 
pylori in terms of severity of gastrointestinal inflammatory tissue changes in 
patients with dyspepsia in Imam Khomeini Hospital. 
Abstract 
Background and Objectives: The objective of this open-label randomized clinical trial was 
compare of three therapeutic regimens (Rabiprazole, Amoxicillin, Bismuth subcitrate, 
Clarithromycin (A), Rabiprazole, Amoxicillin, Clarithromycin (B), Rabiprazole, Amoxicillin, 
Bismuth subcetate, Furazolidone (C)) in eradication of Helicobacter pylori in patients with 
dyspepsia. In this study, the effect of adding Bismuth subcitrate to the treatment regimen of 
Clarithromycin, Amoxicillin and Rabiprazole were also be evaluated.  
Methods: In this open-label randomized clinical trial, 90 patients with dyspepsia and 
Helicobacter pylori infection were included in the study. The subjects were randomly divided 
into three groups and each group was randomly treated with one of the three therapeutic 
regimens. Intervention was done in three groups: Rabiprazole for 6 weeks, Amoxicillin, 
Bismuth subcitrate and Clarithromycin for 2 weeks (A), Rabiprazole for 6 week, Amoxicillin 
and Clarithromycin for 2 weeks (B), Rabiprazole for 6 weeks, Amoxicillin, Bismuth subcetate 
and Furazolidone for 2 weeks (C). Demographic information, history of smoking, alcohol 
consumption, previous upper gastrointestinal bleeding, inflammation of the tissue in the 
pathology report and endoscopic findings were recorded questionnaires. The fecal antigen of the 
Helicobacter pylori was checked four weeks after the end of the treatment. Then the collected 
data were analyzed.  
Results: The rate of eradication of H. pylori in group A was 70%, in group B was 56.66% and 
in group C was 93.33%. There was a significant relationship between the studied groups and the 
results of fecal antigen of Helicobacter pylori. 
Conclusion: According to the results of this study, the effect of Furazolidone treatment regimen 
was significantly better than Clarithromycin therapy regimens. Also, the addition of bismuth had 
a significant effect on the success and effect of the treatment regimen containing 
Clarithromycin. Also, the effect of adding Bismuth subcetate to other therapeutic regimens 
requires further investigation. 
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